SGK integrates insulin and mineralocorticoid regulation of
epithelial sodium transport
Jian
Wang1,*,
Pascal
Barbry1,*,
Anita C.
Maiyar2,
David J.
Rozansky1,
Aditi
Bhargava1,
Meredith
Leong2,
Gary L.
Firestone2, and
David
Pearce1
1 Division of Nephrology, Department of Medicine, and
Department of Cellular and Molecular Pharmacology, University
of California, San Francisco, San Francisco 94143; and
2 Department of Molecular and Cell Biology, University of
California, Berkeley, California 94720
 |
ABSTRACT |
The epithelial Na+ channel (ENaC)
constitutes the rate-limiting step for Na+ transport across
tight epithelia and is the principal target of hormonal regulation,
particularly by insulin and mineralocorticoids. Recently, the
serine-threonine kinase (SGK) was identified as a rapidly
mineralocorticoid-responsive gene, the product of which stimulates
ENaC-mediated Na+ transport. Like its close relative,
protein kinase B (also called Akt), SGK's kinase activity is dependent
on phosphatidylinositol 3-kinase (PI3K), a key mediator of insulin
signaling. In our study we show that PI3K is required for SGK-dependent
stimulation of ENaC-mediated Na+ transport as well as for
the production of the phosphorylated form of SGK. In A6 kidney cells,
mineralocorticoid induction of the phosphorylated form of SGK preceded
the increase in Na+ transport, and specific inhibition of
PI3K inhibited both phosphorylation of SGK and
mineralocorticoid-induced Na+ transport. Insulin both
augmented SGK phosphorylation and synergized with mineralocorticoids in
stimulating Na+ transport. In a Xenopus laevis
oocyte coexpression assay, SGK-stimulated ENaC activity was also
markedly reduced by PI3K inhibition. Finally, in vitro-translated SGK
specifically interacted with the ENaC subunits expressed in
Escherichia coli as glutathione S-transferase fusion proteins. These data suggest that SGK is a PI3K-dependent integrator of insulin and mineralocorticoid actions that interacts with
ENaC subunits to control Na+ entry into kidney collecting
duct cells.
epithelial sodium channel; phosphatidylinositol 3-kinase; serine-threonine kinase
 |
INTRODUCTION |
THE EFFECTS OF
MINERALOCORTICOIDS on Na+ transport in tight
epithelia are mediated by intracellular receptors that modulate the
activity of specific genes (2, 29, 42). After a latent period of ~30-60 min, the earliest detectable effect elicited by
mineralocorticoids is stimulation of apical membrane Na+
transport mediated by the epithelial sodium channel (ENaC) (12, 36). Recently, the serine-threonine kinase, SGK, was identified as a mineralocorticoid-regulated gene, the product of which strongly stimulates ENaC-mediated Na+ transport (8).
SGK mRNA is rapidly increased in response to mineralocorticoids in A6
(frog kidney) cells and rat kidney collecting duct (8), as
well as in primary cultures of rabbit collecting duct (26)
and a variety of other cells and tissues. Furthermore, SGK protein
levels are potently and rapidly increased by mineralocorticoids and,
when coexpressed in Xenopus laevis oocytes, SGK strongly stimulates ENaC-mediated Na+ currents (8, 26).
SGK is highly conserved with >90% identity between mammalian and
amphibian peptide sequences (30).
SGK was originally identified in rat mammary epithelial cells as a
serum and glucocorticoid-regulated gene, the closest relative of which
was protein kinase B (PKB; also called Akt) (Fig.
1), an integral component of the insulin
signaling pathway (45). Like PKB/Akt, SGK activity, as
assessed by its ability to phosphorylate an oligopeptide target in
vitro, is controlled by phosphatidylinositol 3-kinase (PI3K) (20,
28), a lipid kinase that is essential for a variety of receptor
tyrosine kinase actions, most notably those of the insulin receptor.
Interestingly, PI3K appears to be required for most of the events
triggered by insulin, including stimulation of glucose transport via
GLUT-4 and Na+ transport via ENaC (34, 39).
Moreover, insulin has recently been shown to activate SGK kinase
activity in human embryonic kidney fibroblasts in a PI3K-dependent
manner (28). PI3K is activated by recruitment to the
tyrosine phosphorylated insulin receptor in complex with insulin
receptor substrate-1 (see Fig. 9 for schematic). Once localized to the
plasma membrane, PI3K catalyzes the production of 3-phosphorylated
inositide lipids, particularly phosphatidylinositol 3,4,5-triphosphate
(PIP3), the principal mediator of PI3K effects
(39). The immediate upstream regulators of both PKB/Akt
and SGK, 3-phosphoinositide-dependent kinase-1 and 2 (PDK1 and PDK2,
respectively), are strongly activated by direct physical association
with PIP3 through their pleckstrin homology (PH) domains
(11). PDK1 and PDK2 activate PKB/Akt and SGK through
serine phosphorylation in a PIP3-dependent fashion (20, 28). Taken together, these observations suggested
that PI3K activity would be required for SGK-dependent activation of ENaC and thus for mineralocorticoid-stimulated Na+
transport. Furthermore, the central role that PI3K plays in mediating insulin signaling suggested the possibility that SGK might be regulated
by insulin as well. We therefore examined the dependence of ENaC
activity, mineralocorticoid-stimulated Na+ transport and
SGK phosphorylation on PI3K, as well as the role of SGK in
mineralocorticoid-insulin synergy.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic diagram comparing serine-threonine kinase (SGK)
and protein kinase B (PKB; also called Akt). Note that SGK lacks the
pleckstrin homology (PH) domain shared by PKB/Akt and
3-phosphoinositide-dependent kinase-1 and -2 (PDK1 and PDK2,
respectively). (PDK2 has not yet been cloned and it is unknown whether
it has a PH domain.) SGK and PKB/Akt are identical within the PDK1 and
PDK2 substrate sequences (arrows). Rat SGK and PKB/Akt were used for
this comparison.
|
|
 |
METHODS |
A6 cell culture and electrical measurements.
A6 cells, originally obtained from the American Type Culture
Collection, were maintained at 30°C in a humidified incubator with
1% CO2 in culture medium containing 5% fetal bovine
serum, as described (11). For electrical measurements,
cells were seeded on type VI collagen (Sigma)-coated filter inserts
(Costar) at a density of 106 cells/cm2. After
epithelia had developed a stable electrical resistance (~7-10
days), 5% serum substitute with lipid and thyroxine [prepared by the
University of California, San Francisco Cell Culture Facility according
to the method of Bauer et al. (3)] was replaced for standard serum for 3 days, and then cells were treated with 50 µM
LY-294002 (Calbiochem, La Jolla, CA) or vehicle for 0.5 h, followed by 10
7 M dexamethasone or vehicle. Potential
difference and electrical resistance were measured with Millicell-ERS
(Millipore), and the ratio of the potential difference to the
electrical resistance provided an indirect measurement of electrogenic
Na+ transport. Where shown, 100 nM insulin (Sigma) or
vehicle was added 2 h after dexamethasone (see Fig. 7).
Detection of phosphorylated and nonphosphorylated forms of SGK by
immunoblot.
A6 cells were grown and treated as described above. At times shown
below (see Fig. 3), each filter was incubated with 60 µl lysis buffer
containing (in mM) 50 HEPES, pH 7.4, 250 NaCl, 1.5% NP-40, 5 EDTA, 1 phenylmethylsulfonyl fluoride (PMSF), and 0.5 dithiothreitol (DTT)
supplemented with 1× protease inhibitors (Boehringer Mannheim,
Indianapolis, IN) on a rocking platform at 4°C for 30 min. Filters
were then cut out, and cells were scraped and collected into a
microcentrifuge tube. After centrifugation at 4°C for 15 min at
10,000 rpm, the pellet was discarded, and 105 µg protein from each
lysate were separated by 7.5% SDS-PAGE (National Diagnostics, Atlanta,
GA) and transferred to nitrocellulose membranes (Micron Separations,
Wesborough, MA). After blocking with 5% dry milk in PBS/0.1% Tween 20 overnight, the blots were washed with PBS/0.1% Tween 20 and incubated
with rabbit polyclonal antibody raised against rat SGK (1:1,000
dilution) in PBS/0.1% Tween 20 for 1 h at room temperature.
Generation of anti-rat SGK polyclonal antibody has been described
previously (45). After washing with PBS/0.1% Tween 20, the blots were incubated with rabbit Ig, horseradish peroxidase-linked
whole antibody (Amersham Pharmacia Biotech, Gaithersburg, MD) at
1:5,000 dilution in 5% dry milk in PBS/0.1% Tween 20 for 1 h at
room temperature. After a final wash with PBS/0.1% Tween 20, bound
antibody was detected by autoradiography of chemiluminescent signals by
using Hyperfilm (Amersham Pharmacia Biotech). The phosphorylated and
nonphosphorylated forms of SGK were distinguished by their differential
mobilities (28). Autoradiograms were scanned by using a
UMAX PowerLook II scanner interfaced with a Macintosh G4, and bands
were quantitated by using National Institutes of Health Image software.
Expression and electrical measurements in X. laevis oocytes.
Mature female X. laevis oocytes were maintained at 20°C
with a 12:12-h light-dark cycle. Individual females were anesthetized in ice, and oocyte clusters were surgically removed from the ovary. Oocyte clusters were torn apart with forceps in ND-96 medium containing (in mM) 96 NaCl, 2 KCl, 10 HEPES, and 1.8 CaCl2 at pH 7.4. Denuded oocytes were obtained by collagenase digestion (type IA, 370 U/ml, Sigma) during 2 h at room temperature and rinsed several
times in ND-96. Stage 5-6 oocytes were selected and incubated
overnight at 18°C in ND-96 medium with gentamycin (50 mg/ml).
Capped cRNAs were synthesized by SP6 RNA polymerase after linearization
of pSDeasy vectors with BglII (for SGK and
-FLAG-ENaC) or
Afl III (for
- and
-FLAG-ENaC subunits), as described
(8). psDeasy in vitro expression vectors for FLAG-xENaC
were a gift of Dr. Bernard Rossier and Dr. Dmitri Firsov and have been
shown previously to have similar specificity and activity to the
wild-type channel (15).
Healthy oocytes were selected and injected with 50 nl of cRNA
(5-20 ng/ml each). The oocytes were incubated for 2-4 days
after injection in Tris-96 medium (similar to ND-96, except that 91 mM
NaCl was replaced by 91 mM Tris/Cl, pH 7.4) supplemented with gentamycin. For current measurements, oocytes were punctured with two
conventional microelectrodes (filled with 3 M KCl). Voltage-clamp experiments were performed with a GeneClamp 500B voltage-clamp amplifier (Axon, Foster City, CA), kindly provided by Dr. Andy Gray,
(Dept. of Anethesiology, UCSF). The specific ENaC was defined as the
total current recorded at a holding potential of
70 mV, minus the
current recorded at the same holding potential in the presence of 30 mM amiloride.
In vitro interaction of SGK and ENaC subunits.
Construction of expression plasmids for wild-type SGK (WT-SGK),
kinase-dead SGK (KD-SGK), the NH2- and COOH-terminal
deletions of SGK (
N-,
C-SGK), and the catalytic domain only of
SGK (cat-SGK) has been described previously (28).
In vitro transcription and translation of full-length WT-SGK
[1-431 amino acids (aa)], KD-SGK, K127M, (
N-SGK, 60-431
aa), (
C-SGK, 1-355 aa), and (cat-SGK, 60-355 aa) were
performed by using the 2,4,6-trinitrotoluene-coupled rabbit
reticulocyte kit (Promega) in the presence of
[35S]methionine according to the manufacturer's
instructions. Expression plasmids encoding Jun NH2-terminal
kinase (JNK) protein and PDK1 were provided by Dr. J. S. Gutkind
(National Institute of Dental Research, Bethesda, MD) and Dr. B. A. Hemmings (Friedrich Miescher-Institut, Basel, Switzerland) and have
been described previously (10, 32).
Glutathione S-transferase (GST)-ENaC fusion proteins were
engineered and expressed by using the GST purification system (Amersham Pharmacia Biotech) as follows: the COOH-terminal cytoplasmic domains of
the X. laevis
-ENaC (542-633 aa) and
-ENaC
(551-647 aa) were subcloned from the respective full-length
X. laevis ENaCs (gifts of Dr. Jim Stockand) into the GST
containing prokaryotic-expression vector pGEX-4T3 (Amersham Pharmacia
Biotech) by using PCR. Primers for
-subunit amplification were
5'-CACACGGATCCCTGCTACATCGATATTACTAC-3' (sense)
and 5'-CACACCTCGAGTCAGTTCCTTCTACCTCCATTCTC-3' (antisense). Primers for
-subunit amplification were
5'-CACACGGATCCGCCTGGAGCAGGAACCGCAGG-3' (sense) and
5'-CACACCTCGAGTTAGAGTCTTTCTACATCCTCATC-3' (antisense). The
PCR fragments were digested and ligated into the BamH
I/Xho I multiple cloning site of pGEX-4T3, yielding ENaC
COOH-terminal tails fused to the COOH terminus of GST, as confirmed by
nucleotide sequence analysis. The plasmids were then transformed into
BL-21 Escherichia coli for high-level expression
followed by purification on a glutathione-Sepharose column according to
the manufacturer's protocol. GST alone, by using pGEX-4T3, was also
purified in this manner and served as a negative control.
Binding experiments were performed by using 10 µg of GST-
-ENaC
immobilized on glutathione-Sepharose beads incubated with 5 µl of
35S-SGK translation product in 180 µl of binding buffer
(in mM: 20 HEPES-KOH, pH 7.9, 50 KCl, 2.5 MgCl2, 1 DTT, 1.5 PMSF, 10% glycerol, 0.2% NP-40, and 3 µl of normal goat serum/180
µl binding buffer). The slurry was incubated overnight at 4°C on a
nutator, following which the beads were washed five times in wash
buffer (200 mM NaCl, 0.2% Tween 20, 10 mM Tris, pH 7.5, and 0.5%
nonfat dry milk). The pellet was resuspended in 25 µl of 2× SDS
sample buffer, boiled for 5 min, and retained proteins were resolved by
SDS-PAGE. Gels were dried at 60°C followed by autoradiography. Band
intensity was compared with 10% of the
35S-methionine-labeled input.
 |
RESULTS |
PI3K is necessary for mineralocorticoid-induced
Na+ current and phosphorylation of SGK in
A6 cells.
We first examined the effect of PI3K inhibition on
mineralocorticoid-stimulated Na+ transport. A6 cells were
grown to high resistance on permeable supports and incubated in
serum-free medium as described in METHODS. Cells were
treated with the potent highly specific PI3K inhibitor LY-294002
(43) for 0.5 h followed by addition of dexamethasone. As shown in Fig. 2, dexamethasone induced
a rapid increase in transepithelial potential difference (PD) (Fig.
2A) and a drop in electrical resistance (Fig.
2B), consistent with earlier reports (9, 16,
38). Equivalent current (PD/R, where
R = electrical resistance) correspondingly increased
markedly (Fig. 2C). The PI3K inhibitor, LY-294002, had
little effect on basal resistance but completely blocked the
dexamethasone-induced drop in resistance. It also markedly decreased
basal PD and blocked the early PD response to dexamethasone. After ~3
h, PD began to rise slowly (Fig. 2A). As shown in Fig.
2C, LY-294002 completely inhibited the early stimulation of
equivalent current by dexamethasone but did not prevent a delayed
increase in current beginning after ~2 h. Interestingly, after slowly
increasing to the same level as control monolayers (untreated with
hormone or inhibitor), the current generated by cells treated with
LY-294002 and dexamethasone reached a plateau and did not increase
further. These observations are consistent with the idea that basal and
mineralocorticoid-stimulated ENaC activity depend on PI3K, consistent
with another recent report (5).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 2.
Phosphatidylinositol 3-kinase (PI3K) inhibition blocks
the dexamethasone (Dex)-induced early increase in equivalent current in
A6 cells. Cells were treated with the specific PI3K inhibitor,
LY-294002 (LY), for 0.5 h before addition of Dex. Potential
difference (PD) (A) and resistance (R) (B) were
measured at times shown. The derived parameter, equivalent current
(PD/R) is shown in (C). Error bars, SD
(n = 4). Where not shown, error bars were smaller than
data symbols. PD/R were inhibited >90% by 100 µM
amiloride, indicating that the current is largely epithelial
Na+ channel (ENaC) mediated (not shown). The experiment was
performed a total of 5 times on different days with similar results.
|
|
We next examined by immunoblot the abundance and phosphorylation state
of SGK. Depending on gel composition and duration of electrophoresis,
immunoblots reveal two or three closely spaced bands around 58 kDa,
specifically recognized by affinity-purified SGK antibody (see Figs.
3 and 7 and Ref. 45). The
top band(s) corresponds to the phosphorylated forms, and the
bottom band to the nonphosphorylated form of SGK
(28). As shown in Fig. 3, dexamethasone markedly induced
SGK protein expression in both the presence and absence of LY-294002.
The PI3K inhibitor, however, markedly reduced formation of the
top band at all time points (Fig. 3 and Table
1), indicating that phosphorylation was
prevented. LY-294002 also appeared to have a modest effect on the
kinetics and extent of induction of SGK protein levels; however, this
effect did not reach statistical significance (Table
2). These data strongly suggest that
although dexamethasone increases SGK abundance in a largely
PI3K-independent fashion, PI3K is required for SGK's subsequent
phosphorylation.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 3.
PI3K inhibition blocks SGK phosphorylation. After
measurement of PD and resistance (Fig. 2, A and
B), A6 cells were harvested at times shown and immunoblots
were prepared and probed as described in METHODS. Bottom
band, the nonphosphorylated form of SGK; top band(s), the
phosphorylated forms. Representative blots are shown. The experiment
shown was performed a total of 4 times (with the exception of the 24-h
time point that was performed 3 times) with similar results. Data from
all experiments were quantitated by densitometry, and ratio of
phosphorylated to nonphosphorylated (Table 1) and degree of stimulation
(Table 2) were determined.
|
|
View this table:
[in this window]
[in a new window]
|
Table 2.
The principal effect of PI3K inhibition with LY-294002 is to block
formation of the phosphorylated form of SGK
|
|
Effects on Na+ transport are not due
to toxicity of PI3K inhibitors.
The observation that the cells maintained their high electrical
resistance in the presence of LY-294002 for at least 24 h suggested that they were healthy and that effects on Na+
transport were not due to generalized toxicity. To obtain additional evidence of cell viability, we examined the effect of withdrawing LY-294002 on the electrical properties of A6 cells in the presence and
absence of dexamethasone. LY-294002 inhibition of PI3K, unlike that of
wortmannin, was shown previously to be reversible (43). LY-294002 was applied to cells for 24 h in the presence or absence of dexamethasone, and then medium was replaced with LY-294002-free medium without altering of the dexamethasone concentration. As shown in
Fig. 4, within 1 h of removal of
LY-294002, equivalent current (PD/R) increased in the
dexamethasone-treated monolayers, approaching that of cells treated
with dexamethasone in the absence of LY-294002 (compare LY
withdrawal + Dex with Dex alone in Fig. 4). The recovery of cells
untreated with dexamethasone was slower, but, by 6 h after removal
of LY-294002, electrical parameters were nearly back to control values
(LY withdrawal, no Dex). Equivalent current remained unchanged over the
same time period in cells maintained in LY-294002 (LY, no Dex).
Resistance remained stable for up to 28 h in LY-294002; however,
cells maintained in the inhibitor in the absence of dexamethasone for
>28 h began to lose resistance (not shown).

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 4.
A6 cells recover their Na+ transport
properties after withdrawal of LY. A6 cells were treated as in Fig. 2
except that after 24 h of treatment, LY was withdrawn (as shown).
As in Fig. 2, equivalent sodium current was determined by the ratio,
PD/R. Also as in Fig. 2, error bars represent SD
(n = 4), and those not shown were smaller than the size
of the data symbols. The experiment was performed a total of 3 times
with similar results.
|
|
These results suggest that LY-294002 does not have a generalized toxic
effect on the cells for at least 24 h and that its effects are
rapidly reversible, particularly in the presence of dexamethasone. In
further support of the conclusion that the early LY-294002 effect on
Na+ transport was not due to toxicity, we also found that
electrical properties returned to baseline values when the inhibitor
was removed after only 1 h of treatment (not shown). However,
after ~28 h of LY-294002 treatment toxic effects begin to appear.
SGK stimulation of ENaC activity is PI3K dependent in X. laevis
oocytes.
The above observations are consistent with the idea that PI3K-dependent
SGK activity is required for basal and mineralocorticoid-stimulated ENaC activity. To more directly examine the role of PI3K in
SGK-stimulated ENaC activity, a X. laevis oocyte
coexpression system was used. Oocytes, which have endogenous PI3K
activity (25), have been used extensively to study the
activity and regulation of ion transport proteins (6, 8, 15,
17). Oocytes were injected with cRNAs for the ENaC subunits and
SGK and, after 2-4 days incubation, amiloride-sensitive currents
were determined. As shown in Fig. 5,
LY-294002 rapidly inhibited SGK-stimulated ENaC activity in a manner
similar to its effect on equivalent current in A6 cells (Figs. 2 and
3). This effect was reversible in that equivalent current began to
increase within 45 min after removal of LY-294002 and had returned to
baseline by 7 h (Fig. 5). Also consistent with its effect on
Na+ transport in A6 cells, LY-294002 inhibited
ENaC-mediated Na+ transport in both the presence and
absence of SGK, although the effect in the presence of SGK was
substantially greater (Fig. 6).

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 5.
Time course of LY inhibition of ENaC-mediated
Na+ current in Xenopus laevis oocytes. Oocytes
were injected with RNA encoding ENaC subunits with or without SGK, as
shown. After 40 h, electrodes were placed and a stable baseline
was determined. Oocytes were then incubated in buffer containing 100 µM LY (t = 0), where t is time.
ENaC-mediated Na+ current was determined by a 2-electrode
voltage clamp (see METHODS). LY was washed out at
t = 32 min, as shown. At t = 62 min,
current was undetectable. A representative experiment is shown. The
experiment was performed 3 times with similar results. In the absence
of LY, the baseline remained stable over the course of the experiment.
Statistical analysis of pooled data is shown in Fig. 6.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
Inhibition of ENaC-mediated Na+ transport by
LY in X. laevis oocytes. X. laevis oocytes were
injected with ENaC cRNA without (A) or with (B)
SGK mRNAs. After 40 h, oocytes were incubated in LY or buffer for
2 h, and amiloride-sensitive current was determined as in Fig. 5.
LY inhibition of Na+ transport in the presence of SGK was
greater than in its absence (81% in the presence and 52% in the
absence of SGK; P = 0.02 by Student's unpaired
two-tailed t-test, n = 6). Data points
represent average amiloride- inhibitable currents (means ± SE).
|
|
Insulin stimulates Na+ transport and
increases SGK phosphorylation.
PI3K is required for both mineralocorticoid and insulin stimulation of
Na+ transport [see Fig. 2 (4, 34)] as well
as for phosphorylation of SGK [Fig. 3 (28)]. Together
with previous reports that insulin and mineralocorticoids stimulate
Na+ transport synergistically (14, 19), these
observations suggested that the insulin- and
mineralocorticoid-signaling pathways converge at SGK (34).
With these observations in mind, we examined the effects of insulin and
dexamethasone on Na+ transport, and SGK abundance and
phosphorylation in the absence of serum. As shown in Fig.
7, both mineralocorticoids and insulin stimulated Na+ transport (PD/R) in A6 cells
grown in serum-free medium. The change in equivalent current induced by
insulin and dexamethasone together was ~1.5-fold the sum of the
change induced by each separately, indicating a moderate level of
synergy. As shown in Fig. 3, dexamethasone increased both the
phosphorylated and nonphosphorylated forms of SGK. In support of the
idea that the insulin- and mineralocorticoid-signaling pathways
converge at SGK, SGK phosphorylation was further increased by insulin
(compare lanes 2 and 4, Fig. 7,
bottom). In some experiments, insulin appeared to further increase
SGK protein level as well, although this effect was inconsistent and
insulin by itself did not stimulate SGK expression. Due to the low
signal-to-noise ratio in the absence of hormone, the various forms of
SGK could not be separately quantitated and compiled under those
conditions. However, ratios of phosphorylated to nonphosphorylated
forms of SGK could be determined and are shown in the legend to Fig. 7.

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 7.
Insulin increases phosphorylation of SGK and synergizes
with Dex in stimulating equivalent current. A6 cells were cultured and
treated as in Fig. 2. Cells were treated with Dex alone (or vehicle)
for 2 h followed by addition of insulin (or vehicle) for an
additional 0.5 h, as shown. PD and resistance were measured and
cells were harvested and immunoblotted for SGK, as described in
METHODS. Shown are equivalent currents (±SD,
n = 5). Changes in equivalent current relative to no
Dex, no insulin were (in µA/cm2) 4.1 (Dex alone), 5.8 (insulin alone), 15.3 (Dex plus insulin). The change in equivalent
current induced by insulin plus Dex was significantly greater than the
sum of those induced by the each used separately (15.3 vs. 9.9 µA;
P < 0.001 by unpaired Student's t-test).
The experiment was performed a total of 4 times on different days with
similar results. Western blots were performed on 4 independent
monolayers. Bands were quantitated as described in METHODS,
and ratios of phosphorylated to nonphosphorylated SGK were determined.
Average values (±SE) were 0.8 ± 0.01 without Dex or insulin;
0.6 ± 0.03 with Dex, without insulin; 1.5 ± 0.14 without
Dex, with insulin; 1.3 ± 0.19 with both Dex and insulin. Ratio of
phosphorylated to nonphosphorylated SGK was significantly higher in the
presence of insulin (P < 0.01 by unpaired Student's
t-test) but was unaffected by Dex.
|
|
SGK physically interacts with ENaC subunits.
As a first step toward determining the mechanistic basis of SGK
stimulation of ENaC-mediated Na+ transport, we examined
whether SGK physically interacts with the COOH-terminal tails of ENaC
subunits. This region interacts with other putative regulatory proteins
such as Nedd4 (41), and its deletion can result in
increased or decreased Na+ transport depending on which
subunit is affected and the extent of the deletion (2).
These observations point to the COOH-terminal tails of all of the ENaC
subunits as important sites of regulation that might directly interact
with SGK. This possibility was tested for
-ENaC and
-ENaC, by
using GST-pulldown assays of 35S-SGK. GST-
-ENaC and
GST-
-ENaC fusion proteins were expressed in E. coli, bound to glutathione-Sepharose beads, and incubated with the [35S]methionine-labeled in vitro translation
product of full-length SGK. As shown in Fig.
8A, SGK
bound to both GST-
-ENaC and GST-
-ENaC (lanes 4 and
5), whereas it displayed negligible binding to GST alone
(lane 3). The
-ENaC COOH-terminal tail was not
successfully expressed and hence has not yet been tested. The
experiments shown were performed with the phosphorylated form of SGK.
Similar results were obtained with nonphosphorylated SGK (not shown),
indicating that both the active and the inactive forms of the kinase
can interact with ENaC subunits (see DISCUSSION).

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 8.
-ENaC and -ENaC physically interact with SGK
in vitro. A: [35S]methionine-labeled in vitro
translation (IVT) product for full-length wild-type SGK was incubated
with glutathione S-transferase (GST) alone (lane
3), GST- -ENaC (lane 4), or GST- -ENaC (lane
5), as indicated. After recovery of fusion protein on
glutathione-Sepharose beads, the bound fraction was analyzed by
SDS-PAGE and visualized by autoradiography. The unprogrammed lysate did
not contain any IVT product (data not shown), and 10% of the IVT
product (input) is represented in lane 2. B: in
vitro synthesized product for full-length SGK, Jun
NH2-terminal kinase (JNK), or PDK1 was incubated with
GST- -ENaC (lanes 2, 4, and 6), and
proteins bound to the beads were resolved by SDS-PAGE (A).
The IVT designated as input in lanes 1, 3, and
5 denotes 10% of the labeled proteins used in the GST
pulldown assays. C: various fragments of SGK composed of
wild-type full-length SGK [WT-SGK, 1-431 amino acids (aa)],
kinase-dead SGK (KD-SGK, K127M), NH2-terminal (term.)
deleted SGK ( N-SGK, 60-431 aa), COOH-terminal deleted SGK
( C-SGK, 1-355 aa), and catalytic domain only SGK (cat-SGK,
60-355 aa) were synthesized as
[35S]methionine-labeled products (A), and
incubated with either GST alone (lanes 6, 8,
10, 12, and 15) or GST- -ENaC
(lanes 7, 9, 11, 13, and
14), and samples were processed (A). Lanes
1-5 depict 10% of the IVT products included in the binding
reactions. Predicted molecular weights (MW) for each of the SGK
products were WT-SGK and point mutant K127M-47.8 kDa; N-41.2 kDa;
C-39.4 kDa; and cat-32.8 kDa. MW markers are shown (far
left) in A, B, and C.
Discrepancies between predicted and actual MW are likely due to
posttranslational modification (28, 45). Similar results
were obtained in 3 separate experiments.
|
|
To ascertain the specificity of interaction with SGK, the GST-ENaC
fusion proteins were incubated with
[35S]methionine-labeled JNK or PDK1 (both SGKs) and
binding compared with that of [35S]methionine-labeled
SGK. As shown in Fig. 8B, no binding was detectable between
either GST-
-ENaC and JNK or PDK1, whereas under the same conditions,
specific interaction between GST-
-ENaC and SGK was readily apparent
(compare lanes 2, 4, and 6). None of
the in vitro translated products bound GST alone (data not shown).
Similar results were obtained by using GST-
-ENaC (not shown).
The specific regions within SGK involved in binding to
-ENaC were
further characterized by incubating GST-
-ENaC with various SGK
truncations followed by SDS-PAGE as in Fig. 8, A and
B. The different SGK fragments included full-length WT-SGK
(1-431 aa), KD-SGK (K127M), NH2-terminal deletion
mutant of SGK that lacks the first 60 aa (
N-SGK, 60-431 aa),
COOH-terminal deletion mutant of SGK that is devoid of 76 aa at the
COOH end (
C-SGK, 1-355 aa), and SGK sequences encompassing the
catalytic domain (cat-SGK, 60-355 aa). Specific binding between
GST-
-ENaC and SGK was observed in all the fragments tested in
preference to GST alone (Fig. 8C; compare lanes
7, 9, 11, 13, and 14 with 6, 8, 10, 12, and
15), thereby defining the catalytic domain of SGK as a
region mediating interaction with
-ENaC. Figure 8C
(middle) shows 10% of the in vitro translated products of
the SGK deletions used as input for the binding assays. Taken together,
these data demonstrate direct specific association between the
catalytic domain of SGK and
-ENaC, in vitro.
 |
DISCUSSION |
Mineralocorticoid effects on ENaC-mediated
Na+ transport are PI3K dependent.
SGK is a corticosteroid-regulated gene, the product of which activates
the ENaC (8). Its mRNA levels are stimulated by ligands
for either the mineralocorticoid receptor (MR) or glucocorticoid receptor (GR), consistent with previous evidence that MR and GR mediate
similar effects on Na+ transport in kidney collecting duct
cells (9, 27, 38). Although mineralocorticoids increase
SGK abundance (8), it appears that this is not sufficient
to stimulate Na+ transport. Particularly, in light of
recent reports (20, 28), our present data strongly suggest
that PI3K-dependent activation is also required for SGK to stimulate
ENaC-mediated Na+ transport. Figure
9 shows a speculative scheme of
mineralocorticoid-regulated Na+ transport emphasizing the
dual regulation of SGK. According to this view,
mineralocorticoid-dependent stimulation of SGK gene expression is a
necessary, but not sufficient, event in the early activation of
Na+ transport. Additional activation of SGK is required for
the downstream events to occur.

View larger version (112K):
[in this window]
[in a new window]
|
Fig. 9.
A mechanistic view of ENaC regulation by insulin and
mineralocorticoids in tight epithelia. According to this view, SGK is
the principal mediator of insulin and mineralocorticoid effects on
Na+ current, and the extent of synergy between insulin and
mineralocorticoids is determined by the basal level of SGK and the
amount of constitutive PI3K activity. MC, mineralocorticoid; Ins,
insulin; IRS1, insulin receptor substrate-1; PDK,
phosphoinositide-dependent kinase (two isoforms have been identified).
See text for other abbreviations and details of model. In the interest
of simplicity, some key transporters are not shown, for example, the
Na/K-ATPase and the ROMK2 potassium channel. Also, the unknown
activator of basal PI3K activity is not shown (see text for details).
|
|
Although this model explains many of the observed characteristics of
mineralocorticoid-stimulated Na+ transport, several
important points remain unanswered: 1) PI3K inhibition with
LY-294002 disrupts both basal and hormone-stimulated Na+
transport; 2) although insulin increases SGK phosphorylation and synergizes with dexamethasone, SGK is phosphorylated in the absence
of insulin and the extent of synergy is modest; 3) LY-294002 strongly inhibits SGK phosphorylation but also has modest effects on
the kinetics of SGK induction by dexamethasone; and 4) PI3K inhibition greatly reduces the early response to dexamethasone (Figs. 2
and 4) but only blunts the later response. Some of these caveats are
interpretable in light of the present data, whereas others will require
further clarification.
First, the PI3K dependence of basal Na+ current is
consistent with the interpretation shown in Fig. 9, if basal levels of
SGK are not negligible. Western blot data are difficult to interpret in
the absence of mineralocorticoids due to the low signal-to-noise ratio;
however, SGK mRNA and protein have been detected in the basal state
(8). Basal expression of SGK not withstanding, the
important caveat is raised that the dependence of basal current on PI3K
could be due to the activity of another PI3K-dependent kinase such as
SGK2, SGK3, or PKB/Akt (21). Similarly, the efficacy of
insulin in the absence of mineralocorticoids could be due to basal
levels of SGK (more appropriately referred to as SGK1) or to one of the
alternative PI3K-dependent kinases. It is interesting to speculate that
the ratio of active to inactive SGK is as important a determinant of
ENaC activity as the absolute level of the active form (see below).
Further studies are needed to determine whether SGK1 sustains basal
ENaC activity and mediates insulin effects in the absence of
mineralocorticoid. In particular, anti-SGK antibodies with
improved sensitivity and specificity are essential.
Finally, one must address the observation that PI3K inhibition only
blunted the later effect of dexamethasone, consistent with the idea
that the later phase of mineralocorticoid action is, at least in part,
non-PI3K dependent. In this regard, it is interesting to note that
mineralocorticoid effects have long been divided into four distinct
phases: latent, early, middle, and late (reviewed in Ref.
42). The latent phase of mineralocorticoid action
(~30-60 min) appears to be due largely to its dependence on
changes in gene transcription, whereas the early phase (~0.5-3 h) primarily reflects changes in ENaC-mediated apical Na+
transport. In contrast, the middle and late phases (3-24 h)
reflect changes in Na-K-ATPase activity, the metabolic rate of cells, and alterations in membrane surface area (42). It is
interesting to suggest that these later events are PI3K independent;
however, further investigation will be required to address these issues.
SGK is an integrator of mineralocorticoid and insulin
effects.
It is notable that PI3K, a key mediator of insulin signaling, is also
essential for rapid mineralocorticoid regulation of Na+
transport. Insulin strongly stimulates Na+ transport in the
renal tubule including the collecting duct (13), and
synergy between insulin and mineralocorticoids has been reported (14, 19), consistent with our present findings (Fig. 7).
Figure 9 presents a schematic view of SGK as an integrator of insulin and aldosterone actions that account for their synergistic activation of Na+ transport. According to this view, SGK abundance is
regulated by aldosterone through changes in gene transcription while
its activity is controlled by PI3K through phosphorylation; insulin is
a key regulator of PI3K.
It is interesting to note that slightly less than additive (i.e.,
nonsynergistic) effects of aldosterone and insulin were found in at
least one report (35). The basis for the discrepancy between that report and the data referred to above is unknown but could
be explained by variability in basal levels and activities of SGK and
PI3K (the latter determining the ratio of phosphorylated to
nonphosphorylated SGK). For example, if SGK levels and PI3K activity
were low in the absence of mineralocorticoids and insulin, respectively, then mineralocorticoid-insulin synergy would be high.
Conversely, if either were high, then synergy would be low.
It is also possible that other PI3K-dependent kinases are implicated in
insulin-regulated Na+ transport. SGK2 and SGK3 levels are
not regulated by corticosteroids (21), and either or both
of these may contribute to insulin regulation of Na+
transport in the absence of mineralocorticoids. It seems less likely,
but also plausible, that insulin might act through PKB/Akt, which has
overlapping substrate specificities with SGK (20). In
either case, synergy would be high when basal levels of SGK(or related
kinase) are low and, conversely, synergy would be low when basal levels
are high. The roles of SGK, its novel isoforms, and PKB/Akt in
mediating the effects of insulin in the absence of corticosteroids will
require further study. It is interesting to note that our data also
suggest that X. laevis oocytes have significant levels of
SGK or a related PI3K-dependent kinase (Figs. 4 and 5) that is required
for basal ENaC-mediated Na+ transport. Western blots in our
hands have not been sufficiently sensitive to determine the abundance
of oocyte SGK. The role of this PI3K-dependent kinase in oocyte
physiology is uncertain at this time.
Constitutive PI3K activity in A6 cells is high.
In most cells PI3K activity depends on receptor tyrosine kinases (such
as the insulin receptor or platelet-derived growth factor receptor),
and basal activity is low (39). In A6 cells, PI3K activity
and SGK phosphorylation are high in the absence of insulin and are
further stimulated by it [Figs. 3 and 6; (34)]. Consistent with this observation, although both basal and
mineralocorticoid-induced Na+ transport are highly
sensitive to PI3K inhibitors, exogenous activators of PI3K such as
insulin are not absolutely required (Figs. 2 and 6 and Ref.
5). Although an explanation for this observation will
require further investigation, it is plausible that an intracellular
factor such as K-Ras activates PI3K directly (23, 37, 40).
Other possible nonhormonal activators of PI3K include extracellular
matrix components acting through integrins (7) or (less
likely) autocrine factors acting through receptor tyrosine kinases
(33).
A mechanistic view of SGK-stimulated ENaC activity.
It seems likely that SGK stimulates ENaC-mediated Na+
transport by phosphorylating either ENaC subunits themselves or ENaC regulatory proteins (or both). Our data indicate that SGK physically interacts with the
-ENaC and
-ENaC subunits (Fig. 8) in vitro. However, we have not been able to demonstrate direct phosphorylation of
ENaC subunits by SGK (data not shown), consistent with recent reports
showing that mutation of several possible kinase target residues in
ENaC subunits did not affect their ability to be stimulated by SGK
(1, 22). These observations are consistent with the view
that SGK is recruited to its target sites by physical interaction with
ENaC subunit(s) but that the ENaC subunits themselves are not targets
of SGK phosphorylation. Perhaps the direct target of SGK
phosphorylation is a component of the ENaC regulatory machinery. In
this regard, striking parallels between the regulation of
GLUT-4-mediated glucose transport and ENaC-mediated Na+
transport become apparent, perhaps reflecting common themes that underlie the hormonal control of protein trafficking events via intracellular signaling kinases (18, 24, 31). It should be
noted that although the interaction data of Fig. 8 are consistent with
some recent reports (22, 44), they are not consistent with
others (1). Additional investigation will be required to
determine whether SGK interacts with ENaC subunits in vivo and to
further assess the physiological relevance of such an interaction. In
particular, because both phosphorylated and nonphosphorylated forms of
SGK interact with ENaC (Fig. 8 and data not shown), it is important to
determine whether nonphosphorylatable mutants of SGK have dominant
negative activity. Such an observation would have the interesting
implication that the ratio of nonphosphorylated to phosphorylated SGK,
not simply the absolute level, would be an important determinant of
ENaC activity. This could explain the relatively large effects of
LY-294002 and insulin in the absence of mineralocorticoids: LY-294002
decreases, whereas insulin increases, the ratio of nonphosphorylated to
phosphorylated SGK.
According to the schematic view shown in Fig. 9, SGK is recruited to
ENaC-containing vesicles by the ENaC subunits themselves and
phosphorylates vesicle proteins that regulate plasma membrane vesicle
fusion. Although the bulk of evidence now appears to favor changes in
ENaC localization as paramount in increasing apical Na+
transport, it is possible that changes in ENaC open probability might
also play a role (12). In either case, the dual regulation of SGK, its abundance through a transcriptional mechanism, and its
activity through a PI3K-dependent pathway, provides an attractive mechanism for the context-dependent regulation of Na+
transport by mineralocorticoids and insulin.
 |
ACKNOWLEDGEMENTS |
We are grateful to Drs. Andy Gray and Spencer Yost for providing
access to their voltage-clamp apparatus, Drs. Bernard Rossier and
Dmitri Frisov for FLAG-ENaC expression vectors, Dr. Jim Stockand for
X. laevis ENaC plasmids, and Dr. Glen Chertow for help with statistical analysis. Dr. J. S. Gutkind is gratefully acknowledged for expression plasmid encoding JNK protein, and Dr. B. A. Hemmings for expression plasmid encoding PDK-1.
 |
FOOTNOTES |
*
J. Wang and P. Barbry contributed equally to this work.
This work was supported by National Institutes of Health and American
Heart Association Western States Affiliate Grants (D. Pearce),
K08-DK-02723 (D. J. Rozansky), CA-71514 (G. L. Firestone), and by grants from the Centre National de la Recherche Scientifique and
the Association Française de Lutte contre la Mucoviscidose (P. Barbry).
Address for reprint requests and other correspondence: D. Pearce, Div.
of Nephrology, Dept. of Medicine and Dept. of Cellular and Molecular
Pharmacology, Box 0532, Univ. of California, San Francisco, San
Francisco, CA 94143 (E-mail: pearced{at}medicine.ucsf.edu).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 20 June 2000; accepted in final form 18 October 2000.
 |
REFERENCES |
1.
Alvarez de la Rosa, D,
Zhang P,
Naray-Fejes-Toth A,
Fejes-Toth G,
and
Canessa CM.
The serum and glucocorticoid kinase SGK increases the abundance of epithelial sodium channels in the plasma membrane of Xenopus oocytes.
J Biol Chem
274:
37834-37839,
1999[Abstract/Free Full Text].
2.
Barbry, P,
and
Hofman P.
Molecular biology of Na+ absorption.
Am J Physiol Gastrointest Liver Physiol
273:
G571-G585,
1997[Abstract/Free Full Text].
3.
Bauer, RF,
Arthur LO,
and
Fine DL.
Propagation of mouse mammary tumor cell lines and production of mouse mammary tumor virus in a serum-free medium.
In Vitro
12:
558-563,
1976[ISI][Medline].
4.
Blazer-Yost, BL,
Liu X,
and
Helman SI.
Hormonal regulation of ENaCs: insulin and aldosterone.
Am J Physiol Cell Physiol
274:
C1373-C1379,
1998[Abstract/Free Full Text].
5.
Blazer-Yost, BL,
Punescu TG,
Helman SI,
Lee KD,
and
Vlahos CJ.
Phosphoinositide 3-kinase is required for aldosterone-regulated sodium reabsorption.
Am J Physiol Cell Physiol
277:
C531-C536,
1999[Abstract/Free Full Text].
6.
Canessa, CM,
Schild L,
Buell G,
Thorens B,
Gautschi I,
Horisberger JD,
and
Rossier BC.
Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits.
Nature
367:
463-467,
1994[ISI][Medline].
7.
Chen, HC,
and
Guan JL.
Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase.
Proc Natl Acad Sci USA
91:
10148-10152,
1994[Abstract/Free Full Text].
8.
Chen, SY,
Bhargava A,
Mastroberardino L,
Meijer OC,
Wang J,
Buse P,
Firestone GL,
Verrey F,
and
Pearce D.
Epithelial sodium channel regulated by aldosterone-induced protein SGK.
Proc Natl Acad Sci USA
96:
2514-2519,
1999[Abstract/Free Full Text].
9.
Chen, SY,
Wang J,
Liu W,
and
Pearce D.
Aldosterone responsiveness of A6 cells is restored by cloned rat mineralocorticoid receptor.
Am J Physiol Cell Physiol
274:
C39-C46,
1998[Abstract/Free Full Text].
10.
Crespo, P,
Mischak H,
and
Gutkind JS.
Overexpression of mammalian protein kinase C-zeta does not affect the growth characteristics of NIH 3T3 cells.
Biochem Biophys Res Commun
213:
266-272,
1995[ISI][Medline].
11.
Downward, J.
Mechanisms and consequences of activation of protein kinase B/Akt.
Curr Opin Cell Biol
10:
262-267,
1998[ISI][Medline].
12.
Eaton, DC,
Becchetti A,
Ma H,
and
Ling BN.
Renal sodium channels: regulation and single channel properties.
Kidney Int
48:
941-949,
1995[ISI][Medline].
13.
Fidelman, ML,
May JM,
Biber TU,
and
Watlington CO.
Insulin stimulation of Na+ transport and glucose metabolism in cultured kidney cells.
Am J Physiol Cell Physiol
242:
C121-C123,
1982[Abstract/Free Full Text].
14.
Fidelman, ML,
and
Watlington CO.
Insulin and aldosterone interaction on Na+ and K+ transport in cultured kidney cells (A6).
Endocrinology
115:
1171-1178,
1984[Abstract].
15.
Firsov, D,
Schild L,
Gautschi I,
Merillat AM,
Schneeberger E,
and
Rossier BC.
Cell surface expression of the epithelial Na channel and a mutant causing Liddle's syndrome: a quantitative approach.
Proc Natl Acad Sci USA
93:
15370-15375,
1996[Abstract/Free Full Text].
16.
Handler, JS,
Perkins FM,
and
Johnson JP.
Hormone effects on transport in cultured epithelia with high electrical resistance.
Am J Physiol Cell Physiol
240:
C103-C105,
1981[Abstract].
17.
Hediger, MA,
Coady MJ,
Ikeda TS,
and
Wright EM.
Expression cloning and cDNA sequencing of the Na+/glucose co-transporter.
Nature
330:
379-381,
1987[ISI][Medline].
18.
James, DE,
Piper RC,
and
Slot JW.
Targeting of mammalian glucose transporters.
J Cell Sci
104:
607-612,
1993[Free Full Text].
19.
Johnson, JP,
Jones D,
and
Wiesmann WP.
Hormonal regulation of Na+-K+-ATPase in cultured epithelial cells.
Am J Physiol Cell Physiol
251:
C186-C190,
1986[Abstract/Free Full Text].
20.
Kobayashi, T,
and
Cohen P.
Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2.
Biochem J
339:
319-328,
1999[ISI][Medline].
21.
Kobayashi, T,
Deak M,
Morrice N,
and
Cohen P.
Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase.
Biochem J
344:
189-197,
1999[ISI][Medline].
22.
Lang, F,
Klingel K,
Wagner CA,
Stegen C,
Warntges S,
Friedrich B,
Lanzendorfer M,
Melzig J,
Moschen I,
Steuer S,
Waldegger S,
Sauter M,
Paulmichl M,
Gerke V,
Risler T,
Gamba G,
Capasso G,
Kandolf R,
Hebert SC,
Massry SG,
and
Broer S.
Deranged transcriptional regulation of cell-volume sensitive kinase hSGK in diabetic nephropathy.
Proc Natl Acad Sci USA
97:
8157-8162,
2000[Abstract/Free Full Text].
23.
Mastroberardino, L,
Spindler B,
Forster I,
Loffing J,
Assandri R,
May A,
and
Verrey F.
Ras pathway activates epithelial Na+ channel and decreases its surface expression in Xenopus oocytes.
Mol Biol Cell
9:
3417-3427,
1998[Abstract/Free Full Text].
24.
Min, J,
Okada S,
Kanzaki M,
Elmendorf JS,
Coker KJ,
Ceresa BP,
Syu LJ,
Noda Y,
Saltiel AR,
and
Pessin JE.
Synip: a novel insulin-regulated syntaxin 4-binding protein mediating GLUT4 translocation in adipocytes.
Mol Cell
3:
751-760,
1999[ISI][Medline].
25.
Mora, S,
Kaliman P,
Chillaron J,
Testar X,
Palacin M,
and
Zorzano A.
Insulin and insulin-like growth factor I (IGF-I) stimulate GLUT4 glucose transporter translocation in Xenopus oocytes.
Biochem J
311:
59-65,
1995[ISI][Medline].
26.
Naray-Fejes-Toth, A.,
Canessa C,
Cleaveland ES,
Aldrich G,
and
Fejes-Toth G.
SGK is an aldosterone-induced kinase in the renal collecting duct. Effects on epithelial Na+ channels.
J Biol Chem
274:
16973-16978,
1999[Abstract/Free Full Text].
27.
Naray-Fejes-Toth, A,
and
Fejes TG.
Glucocorticoid receptors mediate mineralocorticoid-like effects in cultured collecting duct cells.
Am J Physiol Renal Fluid Electrolyte Physiol
259:
F672-F678,
1990[Abstract/Free Full Text].
28.
Park, J,
Leong ML,
Buse P,
Maiyar AC,
Firestone GL,
and
Hemmings BA.
Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway.
EMBO J
18:
3024-3033,
1999[Abstract/Free Full Text].
29.
Pearce, D.
Steroid hormone response elements.
In: Molecular Nephrology: Kidney Function in Health and Disease, edited by Schlondorff D.,
and Bonventre J.. New York: Dekker, 1995.
30.
Pearce, D,
Verrey F,
Chen SY,
Mastroberardino L,
Meijer OC,
Wang J,
and
Bhargava A.
Role of SGK in mineralocorticoid-regulated sodium transport.
Kidney Int
57:
1283-1289,
2000[ISI][Medline].
31.
Pessin, JE,
Thurmond DC,
Elmendorf JS,
Coker KJ,
and
Okada S.
Molecular basis of insulin-stimulated GLUT4 vesicle trafficking. Location! Location! Location!
J Biol Chem
274:
2593-2596,
1999[Free Full Text].
32.
Pullen, N,
Dennis PB,
Andjelkovic M,
Dufner A,
Kozma SC,
Hemmings BA,
and
Thomas G.
Phosphorylation and activation of p70s6k by PDK1.
Science
279:
707-710,
1998[Abstract/Free Full Text].
33.
Rahimi, N,
Tremblay E,
McAdam L,
Park M,
Schwall R,
and
Elliott B.
Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
Cell Growth Differ
7:
263-70,
1996[Abstract].
34.
Record, RD,
Froelich LL,
Vlahos CJ,
and
Blazer YB.
Phosphatidylinositol 3-kinase activation is required for insulin-stimulated sodium transport in A6 cells.
Am J Physiol Endocrinol Metab
274:
E611-E617,
1998[Abstract/Free Full Text].
35.
Record, RD,
Johnson M,
Lee S,
and
Blazer-Yost BL.
Aldosterone and insulin stimulate amiloride-sensitive sodium transport in A6 cells by additive mechanisms.
Am J Physiol Cell Physiol
271:
C1079-C1084,
1996[Abstract/Free Full Text].
36.
Renard, S,
Voilley N,
Bassilana F,
Lazdunski M,
and
Barbry P.
Localization and regulation by steroids of the alpha, beta and gamma subunits of the amiloride-sensitive Na+ channel in colon, lung and kidney.
Pflügers Arch
430:
299-307,
1995[ISI][Medline].
37.
Rodriguez-Viciana, P,
Warne PH,
Dhand R,
Vanhaesebroeck B,
Gout I,
Fry MJ,
Waterfield MD,
and
Downward J.
Phosphatidylinositol-3-OH kinase as a direct target of RAS.
Nature
370:
527-532,
1994[ISI][Medline].
38.
Schmidt, TJ,
Husted RF,
and
Stokes JB.
Steroid hormone stimulation of Na+ transport in A6 cells is mediated via glucocorticoid receptors.
Am J Physiol Cell Physiol
264:
C875-C884,
1993[Abstract/Free Full Text].
39.
Shepherd, PR,
Withers DJ,
and
Siddle K.
Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.
Biochem J
333:
471-490,
1998[ISI][Medline].
40.
Spindler, B,
Mastroberardino L,
Custer M,
and
Verrey F.
Characterization of early aldosterone-induced RNAs identified in A6 kidney epithelia.
Pflügers Arch
434:
323-331,
1997[ISI][Medline].
41.
Staub, O,
Dho S,
Henry P,
Correa J,
Ishikawa T,
McGlade J,
and
Rotin D.
WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle's syndrome.
EMBO J
15:
2371-2380,
1996[Abstract].
42.
Verrey, F.
Early aldosterone action: toward filling the gap between transcription and transport.
Am J Physiol Renal Physiol
277:
F319-F327,
1999[Abstract/Free Full Text].
43.
Vlahos, CJ,
Matter WF,
Hui KY,
and
Brown RF.
A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY-294002).
J Biol Chem
269:
5241-5248,
1994[Abstract/Free Full Text].
44.
Volk, KA,
Husted RF,
Snyder PM,
and
Stokes JB.
Kinase regulation of hENaC mediated through a region in the COOH-terminal portion of the alpha-subunit.
Am J Physiol Cell Physiol
278:
C1047-C1054,
2000[Abstract/Free Full Text].
45.
Webster, MK,
Goya L,
Ge Y,
Maiyar AC,
and
Firestone GL.
Characterization of SGK, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum.
Mol Cell Biol
13:
2031-2040,
1993[Abstract].
Am J Physiol Renal Fluid Electrolyte Physiol 280(2):F303-F313
0363-6127/01 $5.00
Copyright © 2001 the American Physiological Society